Canadian pilot study suggests prescription icosapent ethyl (VA...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
TORONTO, ON, Dec. 14, 2020 /PRNewswire-AsiaNet/ -- The results of a Canadian study released this weekend provides encouraging data suggesting that the prescription strength omega-3 called icosapent ethyl (VASCEPA) may reduce inflammation and improve symptoms in patients with a diagnosis of COVID-1...
Authors: LATEST ASIANET NEWS RELEASES